OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review
David Cella, Jennifer Evans, Marion Feuilly, et al.
Advances in Therapy (2021) Vol. 38, Iss. 2, pp. 969-993
Open Access | Times Cited: 14
David Cella, Jennifer Evans, Marion Feuilly, et al.
Advances in Therapy (2021) Vol. 38, Iss. 2, pp. 969-993
Open Access | Times Cited: 14
Showing 14 citing articles:
Neuroendocrine tumor theranostics
Yasushi Ichikawa, Noritoshi Kobayashi, Shoko Takano, et al.
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1930-1938
Open Access | Times Cited: 30
Yasushi Ichikawa, Noritoshi Kobayashi, Shoko Takano, et al.
Cancer Science (2022) Vol. 113, Iss. 6, pp. 1930-1938
Open Access | Times Cited: 30
PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Dermot O’Toole, Pamela L. Kunz, Susan M. Webb, et al.
Advances in Therapy (2022) Vol. 40, Iss. 2, pp. 671-690
Open Access | Times Cited: 13
Dermot O’Toole, Pamela L. Kunz, Susan M. Webb, et al.
Advances in Therapy (2022) Vol. 40, Iss. 2, pp. 671-690
Open Access | Times Cited: 13
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
Nicola Silvestris, Tindara Franchina, Marco Gallo, et al.
ESMO Open (2023) Vol. 8, Iss. 6, pp. 102062-102062
Open Access | Times Cited: 7
Nicola Silvestris, Tindara Franchina, Marco Gallo, et al.
ESMO Open (2023) Vol. 8, Iss. 6, pp. 102062-102062
Open Access | Times Cited: 7
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine
Luiz Eduardo Wildemberg, Christhiane Fialho, Mônica R. Gadelha
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 4, pp. 101906-101906
Closed Access | Times Cited: 1
Luiz Eduardo Wildemberg, Christhiane Fialho, Mônica R. Gadelha
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 4, pp. 101906-101906
Closed Access | Times Cited: 1
Evaluating home injection compared with healthcare-setting injection of somatostatin analogs: a systematic literature review
César Luiz Boguszewski, Márta Korbonits, A. Artignan, et al.
Endocrine (2022) Vol. 79, Iss. 3, pp. 527-536
Open Access | Times Cited: 6
César Luiz Boguszewski, Márta Korbonits, A. Artignan, et al.
Endocrine (2022) Vol. 79, Iss. 3, pp. 527-536
Open Access | Times Cited: 6
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey
Jorge Hernando, Teodora Kolarova, Chris Verslype, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 6
Open Access | Times Cited: 3
Jorge Hernando, Teodora Kolarova, Chris Verslype, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 6
Open Access | Times Cited: 3
An international simulated-use study to assess nurses’ preferences between two lanreotide syringes for patients with neuroendocrine tumours or acromegaly (PRESTO 3)
Diego Ferone, Wendy Martin, Jesse W. Williams, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 2, pp. 421-432
Open Access | Times Cited: 3
Diego Ferone, Wendy Martin, Jesse W. Williams, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 2, pp. 421-432
Open Access | Times Cited: 3
A qualitative study to understand the experience of somatostatin analog treatments from the perspective of patients with neuroendocrine tumors
Caroline Seo, Erica Horodniceanu, Rachel Shah, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 7, pp. 6307-6316
Open Access | Times Cited: 3
Caroline Seo, Erica Horodniceanu, Rachel Shah, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 7, pp. 6307-6316
Open Access | Times Cited: 3
Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?
Anna Sowa‐Staszczak, Marta Opalińska, Anna Kurzyńska, et al.
Medicina (2021) Vol. 57, Iss. 12, pp. 1287-1287
Open Access | Times Cited: 3
Anna Sowa‐Staszczak, Marta Opalińska, Anna Kurzyńska, et al.
Medicina (2021) Vol. 57, Iss. 12, pp. 1287-1287
Open Access | Times Cited: 3
Evaluating Home Injection Compared with Healthcare-Setting Injection of Somatostatin Analogs: A Systematic Literature Review
César Luiz Boguszewski, A. Artignan, Márta Korbonits, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
César Luiz Boguszewski, A. Artignan, Márta Korbonits, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Preference of acromegaly patients for treatment attributes in Spain
Marcos Díaz-Muñoz, Carmen Fajardo, Cristina Álvarez‐Escolá, et al.
Research Square (Research Square) (2023)
Open Access
Marcos Díaz-Muñoz, Carmen Fajardo, Cristina Álvarez‐Escolá, et al.
Research Square (Research Square) (2023)
Open Access
Preference of acromegaly patients for treatment attributes in Spain
Carmen Fajardo, Cristina Álvarez‐Escolá, Betina Biagetti, et al.
Endocrine (2023) Vol. 82, Iss. 2, pp. 379-389
Open Access
Carmen Fajardo, Cristina Álvarez‐Escolá, Betina Biagetti, et al.
Endocrine (2023) Vol. 82, Iss. 2, pp. 379-389
Open Access
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours
Jens Otto Lunde Jørgensen, Wouter W. de Herder, Wendy A. Martin, et al.
Advances in Therapy (2023) Vol. 40, Iss. 10, pp. 4675-4688
Closed Access
Jens Otto Lunde Jørgensen, Wouter W. de Herder, Wendy A. Martin, et al.
Advances in Therapy (2023) Vol. 40, Iss. 10, pp. 4675-4688
Closed Access
A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada
Winson Y. Cheung, Callahan LaForty, A Liovas, et al.
Pancreas (2022) Vol. 51, Iss. 9, pp. 1146-1152
Open Access
Winson Y. Cheung, Callahan LaForty, A Liovas, et al.
Pancreas (2022) Vol. 51, Iss. 9, pp. 1146-1152
Open Access
